OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma
Sung‐Hoon Jung, Jae‐Sook Ahn, Yeo-Kyeoung Kim, et al.
BMC Cancer (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 30
Sung‐Hoon Jung, Jae‐Sook Ahn, Yeo-Kyeoung Kim, et al.
BMC Cancer (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
PET/CT in Non-Hodgkin Lymphoma: An Update
Lucia Zanoni, Davide Bezzi, Cristina Nanni, et al.
Seminars in Nuclear Medicine (2022) Vol. 53, Iss. 3, pp. 320-351
Closed Access | Times Cited: 42
Lucia Zanoni, Davide Bezzi, Cristina Nanni, et al.
Seminars in Nuclear Medicine (2022) Vol. 53, Iss. 3, pp. 320-351
Closed Access | Times Cited: 42
Predictive Value of PET Response Combined with Baseline Metabolic Tumor Volume in Peripheral T-Cell Lymphoma Patients
Anne‐Ségolène Cottereau, Tarec Christoffer El‐Galaly, Stéphanie Becker, et al.
Journal of Nuclear Medicine (2017) Vol. 59, Iss. 4, pp. 589-595
Open Access | Times Cited: 52
Anne‐Ségolène Cottereau, Tarec Christoffer El‐Galaly, Stéphanie Becker, et al.
Journal of Nuclear Medicine (2017) Vol. 59, Iss. 4, pp. 589-595
Open Access | Times Cited: 52
Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphoma
Neha Mehta‐Shah, Kimiteru Ito, Kurt S. Bantilan, et al.
Blood Advances (2019) Vol. 3, Iss. 2, pp. 187-197
Open Access | Times Cited: 42
Neha Mehta‐Shah, Kimiteru Ito, Kurt S. Bantilan, et al.
Blood Advances (2019) Vol. 3, Iss. 2, pp. 187-197
Open Access | Times Cited: 42
Prognostic value of baseline, interim and end-of-treatment 18F-FDG PET/CT parameters in extranodal natural killer/T-cell lymphoma: A meta-analysis
Hongxi Wang, Guohua Shen, Chong Jiang, et al.
PLoS ONE (2018) Vol. 13, Iss. 3, pp. e0194435-e0194435
Open Access | Times Cited: 35
Hongxi Wang, Guohua Shen, Chong Jiang, et al.
PLoS ONE (2018) Vol. 13, Iss. 3, pp. e0194435-e0194435
Open Access | Times Cited: 35
Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial
Christine Hanoun, Jan Rekowski, Stefan Müller, et al.
Hematological Oncology (2020) Vol. 38, Iss. 3, pp. 244-256
Open Access | Times Cited: 22
Christine Hanoun, Jan Rekowski, Stefan Müller, et al.
Hematological Oncology (2020) Vol. 38, Iss. 3, pp. 244-256
Open Access | Times Cited: 22
Interim FDG-PET/CT for Response Assessment of Lymphoma
Merissa N. Zeman, Esma A. Akin, Reid W. Merryman, et al.
Seminars in Nuclear Medicine (2022) Vol. 53, Iss. 3, pp. 371-388
Closed Access | Times Cited: 13
Merissa N. Zeman, Esma A. Akin, Reid W. Merryman, et al.
Seminars in Nuclear Medicine (2022) Vol. 53, Iss. 3, pp. 371-388
Closed Access | Times Cited: 13
Treatment approaches in relapsed or refractory peripheral T-cell lymphomas
Cheryl J. Foster, John Kuruvilla
F1000Research (2020) Vol. 9, pp. 1091-1091
Open Access | Times Cited: 16
Cheryl J. Foster, John Kuruvilla
F1000Research (2020) Vol. 9, pp. 1091-1091
Open Access | Times Cited: 16
Utility of18fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma
Sarah McCue Horwitz, Bertrand Coiffier, Francine M. Foss, et al.
Annals of Oncology (2015) Vol. 26, Iss. 4, pp. 774-779
Open Access | Times Cited: 17
Sarah McCue Horwitz, Bertrand Coiffier, Francine M. Foss, et al.
Annals of Oncology (2015) Vol. 26, Iss. 4, pp. 774-779
Open Access | Times Cited: 17
Predictive value of 18F-FDG PET/CT in adults with T-cell lymphoblastic lymphoma: post hoc analysis of results from the GRAALL-LYSA LLO3 trial
Stéphanie Becker, Thomas Vermeulin, Anne‐Ségolène Cottereau, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2017) Vol. 44, Iss. 12, pp. 2034-2041
Closed Access | Times Cited: 17
Stéphanie Becker, Thomas Vermeulin, Anne‐Ségolène Cottereau, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2017) Vol. 44, Iss. 12, pp. 2034-2041
Closed Access | Times Cited: 17
Utility of PET-CT for Evaluation of Patients With Peripheral T-cell Lymphoma
Ronit Gurion, Hanna Bernstine, Liran Domachevsky, et al.
Clinical Lymphoma Myeloma & Leukemia (2018) Vol. 18, Iss. 10, pp. 687-691
Closed Access | Times Cited: 15
Ronit Gurion, Hanna Bernstine, Liran Domachevsky, et al.
Clinical Lymphoma Myeloma & Leukemia (2018) Vol. 18, Iss. 10, pp. 687-691
Closed Access | Times Cited: 15
The contribution of metabolic parameters of FDG PET/CT prior and during therapy of adult patients with lymphomas
Juan Carlos Prieto-Prieto, Juan Antonio Vallejo Casas, Eleftheria Hatzimichael, et al.
Annals of Nuclear Medicine (2020) Vol. 34, Iss. 10, pp. 707-717
Closed Access | Times Cited: 13
Juan Carlos Prieto-Prieto, Juan Antonio Vallejo Casas, Eleftheria Hatzimichael, et al.
Annals of Nuclear Medicine (2020) Vol. 34, Iss. 10, pp. 707-717
Closed Access | Times Cited: 13
Prognostic role of ΔMTV and ΔTLG in Burkitt lymphoma
Domenico Albano, Alessandro Re, Alessandra Tucci, et al.
Annals of Nuclear Medicine (2019) Vol. 33, Iss. 4, pp. 280-287
Closed Access | Times Cited: 13
Domenico Albano, Alessandro Re, Alessandra Tucci, et al.
Annals of Nuclear Medicine (2019) Vol. 33, Iss. 4, pp. 280-287
Closed Access | Times Cited: 13
Correlations Between Imaging Biomarkers and Proliferation Index Ki-67 in Lymphomas: A Systematic Review and Meta-Analysis
Hans‐Jonas Meyer, Andreas Wienke, Alexey Surov
Clinical Lymphoma Myeloma & Leukemia (2019) Vol. 19, Iss. 6, pp. e266-e272
Closed Access | Times Cited: 9
Hans‐Jonas Meyer, Andreas Wienke, Alexey Surov
Clinical Lymphoma Myeloma & Leukemia (2019) Vol. 19, Iss. 6, pp. e266-e272
Closed Access | Times Cited: 9
PET/CT-Based Response Evaluation in Cancer—a Systematic Review of Design Issues
Oke Gerke, Karen Ehlers, Edith Motschall, et al.
Molecular Imaging and Biology (2019) Vol. 22, Iss. 1, pp. 33-46
Closed Access | Times Cited: 9
Oke Gerke, Karen Ehlers, Edith Motschall, et al.
Molecular Imaging and Biology (2019) Vol. 22, Iss. 1, pp. 33-46
Closed Access | Times Cited: 9
The prognostic role of 18F-FDG PET/CT baseline quantitative metabolic parameters in peripheral T-cell lymphoma
Jun Xia, Huayuan Zhu, Jin‐Hua Liang, et al.
Journal of Cancer (2019) Vol. 10, Iss. 23, pp. 5805-5811
Open Access | Times Cited: 9
Jun Xia, Huayuan Zhu, Jin‐Hua Liang, et al.
Journal of Cancer (2019) Vol. 10, Iss. 23, pp. 5805-5811
Open Access | Times Cited: 9
Correlation Between Uptake of 18F-FDG During PET/CT and Ki-67 Expression in Patients Newly Diagnosed With Multiple Myeloma Having Extramedullary Involvement
Qian Li, Jing Ma, Han Li, et al.
Technology in Cancer Research & Treatment (2019) Vol. 18
Open Access | Times Cited: 8
Qian Li, Jing Ma, Han Li, et al.
Technology in Cancer Research & Treatment (2019) Vol. 18
Open Access | Times Cited: 8
Validation of Convolutional Neural Networks for Fast Determination of Whole-Body Metabolic Tumor Burden in Pediatric Lymphoma
Elba Etchebehere, Rebeca Andrade, Mariana Camacho, et al.
Journal of Nuclear Medicine Technology (2022) Vol. 50, Iss. 3, pp. 256-262
Open Access | Times Cited: 5
Elba Etchebehere, Rebeca Andrade, Mariana Camacho, et al.
Journal of Nuclear Medicine Technology (2022) Vol. 50, Iss. 3, pp. 256-262
Open Access | Times Cited: 5
CT findings predict survival of patients with peripheral T cell lymphoma: a preliminary study
Wenbin Yang, Sen Jiang, JianBang Lin, et al.
Radiology and Oncology (2019) Vol. 53, Iss. 1, pp. 31-38
Open Access | Times Cited: 5
Wenbin Yang, Sen Jiang, JianBang Lin, et al.
Radiology and Oncology (2019) Vol. 53, Iss. 1, pp. 31-38
Open Access | Times Cited: 5
Prognostic significance of FDG-PET/CT in determining upfront autologous stem cell transplantation for the treatment of peripheral T cell lymphomas
Seo‐Yeon Ahn, Seung-Yeon Jung, Sung‐Hoon Jung, et al.
Annals of Hematology (2019) Vol. 99, Iss. 1, pp. 83-91
Closed Access | Times Cited: 5
Seo‐Yeon Ahn, Seung-Yeon Jung, Sung‐Hoon Jung, et al.
Annals of Hematology (2019) Vol. 99, Iss. 1, pp. 83-91
Closed Access | Times Cited: 5
Prognostic value of interim 18F-FDG PET/CT in T-cell lymphomas
Long Qian, Miao-Ming Yan, Wei Zhang, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2019) Vol. 61, Iss. 4, pp. 927-933
Closed Access | Times Cited: 4
Long Qian, Miao-Ming Yan, Wei Zhang, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2019) Vol. 61, Iss. 4, pp. 927-933
Closed Access | Times Cited: 4
Correlations between maximum standardized uptake value measured via18F-fluorodeoxyglucose positron emission tomography/computed tomography and clinical variables and biochemical indicators in adult lymphoma
Hongling Li, Xiaohuan Wang, Lingfang Zhang, et al.
Journal of Cancer Research and Therapeutics (2019) Vol. 15, Iss. 7, pp. 1581-1581
Open Access | Times Cited: 4
Hongling Li, Xiaohuan Wang, Lingfang Zhang, et al.
Journal of Cancer Research and Therapeutics (2019) Vol. 15, Iss. 7, pp. 1581-1581
Open Access | Times Cited: 4
The role of pre-treatment and mid-treatment 18F-FDG PET/CT imaging in evaluating prognosis of peripheral T-cell lymphoma-not otherwise specified (PTCL-NOS)
Yafei Zhang, Guangfa Wang, Xin Zhao, et al.
BMC Medical Imaging (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Yafei Zhang, Guangfa Wang, Xin Zhao, et al.
BMC Medical Imaging (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 4
18 F-FDG-PET/CT response after first-line treatment as a prognostic factor for survival in peripheral T-cell lymphoma: a Spanish retrospective study
Raúl Córdoba, Joaquín Sánchez‐García, Eva Domingo‐Domènech, et al.
Expert Review of Hematology (2024) Vol. 17, Iss. 1-3, pp. 95-100
Open Access
Raúl Córdoba, Joaquín Sánchez‐García, Eva Domingo‐Domènech, et al.
Expert Review of Hematology (2024) Vol. 17, Iss. 1-3, pp. 95-100
Open Access
Pre-treatment [ 18 F]FDG PET/CT for assessing bone marrow involvement and prognosis in patients with newly diagnosed peripheral T-cell lymphoma
Jing Chen, Yi Zhao
Hematology (2024) Vol. 29, Iss. 1
Open Access
Jing Chen, Yi Zhao
Hematology (2024) Vol. 29, Iss. 1
Open Access
PET/CT in Hematological Malignancies: What Has Been Achieved and What Remains to Be Done
А. С. Субботин, А. И. Пронин, Т. М. Гелиашвили, et al.
Clinical oncohematology (2024) Vol. 17, Iss. 2, pp. 109-128
Open Access
А. С. Субботин, А. И. Пронин, Т. М. Гелиашвили, et al.
Clinical oncohematology (2024) Vol. 17, Iss. 2, pp. 109-128
Open Access
